These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 82214)

  • 1. [Role of VM26 on glioma cells in vitro--analysis of G0 cells and recruitment (author's transl)].
    Yamamoto H; Shitara N; Nomura K; Basugi N; Takakura K; Sano K
    Neurol Med Chir (Tokyo); 1978 Aug; 18(6):503-13. PubMed ID: 82214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cell kinetic studies on synchronized glioma cells in vitro with special reference to the mode of action of chemotherapeutic agents (author's transl)].
    Yamamoto H; Matsutani M
    No To Shinkei; 1981 Aug; 33(8):781-93. PubMed ID: 7284204
    [No Abstract]   [Full Text] [Related]  

  • 3. Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.
    Bogdahn U; Zapf J; Weber H; Dünisch G; Löbering HG; Martin R; Mertens HG
    Br J Cancer; 1987 Feb; 55(2):153-8. PubMed ID: 2434122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment-chemoradiotherapy with VM 26 (epipodophyllotoxin) for induction treatment of malignant brain tumours.
    Yamamoto H; Shitara N; Takakura K; Sano K
    Acta Neurochir Suppl (Wien); 1979; 28(2):616-8. PubMed ID: 290264
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH; Musial ST; Brattain MG
    Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhanced cytotoxicity of VM-26 in human malignant glioma cells by calcium channel blocker nicardipine in vitro].
    Hu S; Huang C; Chen B
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):143-6. PubMed ID: 11938773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors.
    Issell BF; Tihon C; Curry ME
    Cancer Chemother Pharmacol; 1982; 7(2-3):113-5. PubMed ID: 7083450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
    Long BH; Musial ST; Brattain MG
    Cancer Res; 1985 Jul; 45(7):3106-12. PubMed ID: 3839166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems of the action of cyclic AMP on malignant brain tumors (author's transl)].
    Nagai M; Teraoka A; Furihata T; Nomura K; Matsutani M
    No Shinkei Geka; 1974; 2(7-8):511-9. PubMed ID: 4374664
    [No Abstract]   [Full Text] [Related]  

  • 10. [The inhibitory effects of corticosteroid on the proliferation of tumor cells derived from human astrocytoma-gliobastoma--with special reference to combined vasopressin--corticosteroid therapy (author's transl)].
    Kajikawa H
    No Shinkei Geka; 1975 Jan; 3(1):51-6. PubMed ID: 1238914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
    Yalowich JC; Fry DW; Goldman ID
    Cancer Res; 1982 Sep; 42(9):3648-53. PubMed ID: 6179605
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surgically treated supratentorial gliomas in the adult. Favourable action of a podophyllin derivative (VM 26) administered alone (author's transl)].
    Trouillas P; Chassard JL; Tommasi M; Aimard G; Devic M
    Nouv Presse Med; 1978 Dec; 7(44):4017-9. PubMed ID: 733569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K; Kohno K; Takano H; Sato S; Kiue A; Kuwano M
    Cancer Res; 1990 Sep; 50(18):5819-24. PubMed ID: 2168282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
    Pritchard J; Whelan R; Hill BT
    Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.
    Broggini M; Colombo T; D'Incalci M
    Cancer Treat Rep; 1983 Jun; 67(6):555-9. PubMed ID: 6861161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
    Buge A; Poisson M; Pouillart P
    Rev Neurol (Paris); 1978 May; 134(5):369-77. PubMed ID: 364592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
    Jankowski RP; Vahrson H
    Med Klin; 1977 Dec; 72(49):2122-6. PubMed ID: 337083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the epipodophyllotoxin derivative VM 26 in mitosis and in interphase.
    Stähelin H; Poschmann G
    Oncology; 1978; 35(5):217-9. PubMed ID: 103022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant gliomas treated by combination chemotherapy and delayed radiation therapy (author's transl)].
    Poisson M; Pouillart P; Bataini JP; Hauw JJ; Pertuiset BF
    Sem Hop; 1981 Feb 8-15; 57(5-6):229-35. PubMed ID: 6259741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monstrocellular brain sarcoma. An "in vitro" study (author's transl)].
    Bronzini E
    Pathologica; 1978; 70(999-1000):79-88. PubMed ID: 652398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.